Introduction
============

The cochlea, the vestibular receptors, the semi-circular canals, and the otolith organs are closely related in terms of anatomy and phylogeny. They share the continuous membranous labyrinth of the inner ear, have similar receptor cells, and are supplied by a common arterial vessel, the labyrinthine artery, which arises from the anterior inferior cerebellar artery (AICA). [@JR1081or-1] It is reasonable to hypothesize that inner ear diseases may affect both the vestibular system and the cochlea, or, in other words, that people with cochlear hearing damage may also have vestibular deficiency. Therefore, patients with moderate to profound sensorineural hearing loss (MPSHL) should have their vestibular organ functions tested. [@JR1081or-2] A comprehensive evaluation of the extent of the vestibular lesions involved in MPSHL may be useful to understand the range and extent of inner ear lesions, and provide some tips on the potential pathogenesis. [@JR1081or-3] In recent years, there has been a growing awareness of vestibular dysfunction in people with hearing loss (HL). The cervical vestibular-evoked myogenic potentials (cVEMPs) is an objective and non-invasive test, which allows the rating of saccular function and lower vestibular nerve. Particular sounds, sent to the ears at a certain frequency and intensity, stimulate a reflex contraction and subsequent release of the neck muscles, specifically the sternocleidomastoid muscle (SCM), in response to the excitation of the saccule; this is called vestibulo-collic reflex. The cVEMP response is recorded as a bioelectric potential variation, with the appearance of two wave patterns. [@JR1081or-1]

There are different causes of MPSHL that are encountered in the otology clinical practice. Congenital HL can be syndromic or non-syndromic. The major risk factors for congenital HL include consanguinity (genetic causes) or intrauterine infections, such as maternal rubella or cytomegalovirus (CMV), that cause bilateral MPSHL in children. [@JR1081or-4] The etiological factors of acquired MPSHL are varied. A previously reported analysis of 310 adult cases included meningitis, viruses, vascular diseases, idiopathic sudden sensorineural HL, chronic suppurative otitis media, trauma, ototoxic medications, and unknown etiology as causes of acquired MPSHL. [@JR1081or-5] [@JR1081or-6] [@JR1081or-7] [@JR1081or-8] [@JR1081or-9] [@JR1081or-10] [@JR1081or-11]

We proposed the present study to increase the current knowledge about the etiopathogenesis of sensorineural HL, which is often of unknown nature.

The aim of the present study was to evaluate the incidence of vestibular abnormalities in patients with MPSHL. Another purpose was to study the correlation between the etiology of HL and a possible alteration in labyrinthine function.

Materials and Methods
=====================

We performed a case-control retrospective study. In the case group, 20 people with the following inclusion criteria were enrolled: patients older than 18 years with MPSHL of known etiology, and type-A tympanograms. The exclusion criteria were: syndromic patients, deafness caused by stapedial or cochlear otosclerosis, and patients with previous ear surgery. The control group was composed of 15 people older than 18 years of age, with normal hearing and type-A tympanograms.

The case group was divided into four subgroups based on the etiology ( [Table 1](#TB1081or-1){ref-type="table"} ). They were composed of:

-   two patients with HL after bacterial meningitis, diagnosed by lumbar puncture; [@JR1081or-12]

-   four patients with HL after viral infection in childhood; [@JR1081or-13]

-   six patients with congenital non-syndromic HL; [@JR1081or-14] and

-   eight patients with HL and previous ischemic episodes. These patients had cardiovascular and thrombophilic risk factors (hypercholesterolemia, hyperhomocysteinemia, high factor VIII, elevated plasminogen activator inhibitor-1 levels, and anticardiolipin antibodies). [@JR1081or-15] [@JR1081or-16]

###### Patients in the case group

  CASES     EAR   P1 (ms)                            N1 (ms)   P1-N1 (µv)             PTA dBHL   Etiology
  --------- ----- ---------------------------------- --------- ---------------------- ---------- ------------
  Case-A    Dx    12.4                               21.6      45.6                   87.5       Vascular
            Sx    16                                 22.8      71.6                   88         
  Case-B    Dx    Absent bilateral cVemp responses   \> 90     Bacterial meningitis              
            Sx    \> 90                                                                          
  Case-C    Dx    13                                 21.4      44.5                   88.6       Vascular
            Sx    13.5                               23.9      39.2                   \> 90      
  Case-D    Dx    13.9                               25.4      42.8                   76         Vascular
            sx    14.7                               24.7      109                    70         
  Case-E    Dx    Absent bilateral cVemp responses   82.5      Viral                             
            Sx    \> 90                                                                          
  Case-F    Dx    14.3                               22.8      79.4                   \> 90      Viral
            Sx    14.6                               22.6      105.6                  \> 90      
  Case-G    Dx    Absent bilateral cVemp responses   \> 90     Viral                             
            Sx    \> 90                                                                          
  Case- H   Dx    19.3                               28.3      34.4                   75         Congenital
            Sx    10.2                               23.2      28.6                   72.5       
  Case-I    Dx    13.5                               21.3      13.6                   46         Vascular
            Sx    14                                 21.3      18.7                   55         
  Case-J    Dx    13.4                               23        116.1                  \> 90      Viral
            Sx    17.9                               26.6      106.6                  \> 90      
  Case-K    Dx    19.8                               26.5      69.7                   \> 90      Congenital
            Sx    17.5                               25.8      28.4                   \> 90      
  Case-L    Dx    13                                 19.8      72.4                   67.5       Vascular
            Sx    Absent cVEMP response              88.4                                        
  Case-M    Dx    Absent cVemp responses             90        Vascular                          
            Sx    13.2                               24.3      69.7                   75.5       
  Case-N    Dx    12.4                               21.3      16.6                   64.8       Congenital
            Sx    13                                 22        33.5                   69         
  Case-O    Dx    13.2                               24.3      116                    78.7       Vascular
            Sx    Absent cVEMP response              \> 90                                       
  Case-P    Dx    12.7                               22.3      74.3                   62.5       Congenital
            Sx    13.2                               24.1      69.5                   63.7       
  Case-Q    Dx    18.4                               24.5      62.4                   87         Congenital
            Sx    17                                 26.2      54.1                   85         
  Case-R    Dx    Absent bilateral cVemp responses   \> 90     Bacterial meningitis              
            Sx    90                                                                             
  Case-S    Dx    13.4                               23.5      37.7                   72.4       Congenital
            Sx    14                                 25        41.3                   83.2       
  Case-T    Dx    16.5                               21.4      73.3                   87         Vascular
            Sx    12.8                               22.5      69.6                   \> 90      

Abbreviations: dBHL, decibels hearing level; Dx, Right; PTA, pure tone average; Sx, Left.

Notes: P1 (ms) and M1 (ms), latency of each of the biphasic complexes in milliseconds; P1-N1 (µv), amplitude of the biphasic complexes in microvolts; PTA dBHL, pure tone average of the hearing threshold at 500, 1,000, 2,000, and 4,000 Hz.

Pure tone audiometry was performed to determine the minimum audibility with a range of 125 to 8,000 Hz by air, and with a range of 250 to 4,000 Hz for bone conduction. The pure tone average (PTA) of the hearing threshold levels at a set of specified frequencies (500, 1,000, 2,000, and 4,000 Hz) was computed. The 2010 version of the Neuro-Audio amplifier (Neurosoft, Ivanovo, Ivanovo Oblast, Russia) was used to measure the cVEMPs.

The cVEMPs were measured with the subject sitting down. The electrodes were well positioned after adequately cleaning the skin. The results were negative in the middle third of the SCM; positive in the middle of the manubrium; and common in the forehead.

To activate the SCM, during the exam, it is necessary that the subject tone up muscle turning his/her head to the side opposite to the one being tested. The parameters of the stimuli used are tone burst to 500 Hz with 4-ms rise and fall times and 0-ms plateau, with a stimulation rate of 5.1/s, in rarefaction polarity. The acquisition parameters are filtering 5/500 Hz in a 50-ms window of time, with an impedance lower than 5 kΩ. The examination was performed by sending to the ears a stimulus of 105 dB NHL. We calculated the presence of the early biphasic P1-N1 complex and its latency (ms) and amplitude (µv). The cVEMP response consists of an initial positivity (P1) followed by a negativity (N1). It is an evoked potential. Although P1 is positive, it is deemed negative on many cVEMPs because of electrode placement (basically putting them on backwards). The most reliable measure of the cVEMP response is the amplitude. [@JR1081or-17] [@JR1081or-18] [@JR1081or-19] [@JR1081or-20]

The statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS, IBM SPSS Statistics, Armonk, NY, US) software, version 25.0. The data are presented as means with standard deviations or frequencies with percentages. Data normality was assessed using the Kolmogorov-Smirnov test of normality. The Man-Whitney U test was used to compare latency and amplitude in the case and control groups. Analysis of Variance (ANOVA) was used to compare latency and amplitude in the sub-groups of the population with HL. The Student *t* test was used to compare the ages of the groups. The Fisher exact test was used for the comparisons of the gender distribution, to evaluate the percentage of the presence of early biphasic P1-N1complex in the case and control groups, and the percentage of the same complex in the sub-groups of the population with HL. Given that the sample was numerically small,l *p* -values ≤ 0.01 were considered statistically significant.

Results
=======

The case group consisted of 20 subjects (65% male and 35% female) with MPSHL and a mean age of 31.1 years (range: 18 to 79 years).

The control group consisted of 15 subjects (60% male and 40% female), with normal hearing and an average age of 27.2 years (range: 15 to 44 years). There were no statistically significant differences regarding age and gender ( *p*  = 0.092; *p*  = 0.762 respectively) between the case and control groups.

The patients of the study group had PTA thresholds between 44.5 dB HL and 90 dB HL or higher.

The subjects in the control group had normal hearing thresholds, lower or equal to 20 dB HL.

The study was performed on 35 subjects (70 ears), and it highlighted the presence of the early biphasic P1-N1 complex in 29 out of 40 (71.5%) ears in the study group, while in the control group, the presence of the P1- N1 complex was detected all of the 30 ears examined. This data was statistically significant ( *p*  = 0.001).

There were no statistically significant differences in the comparison between the latencies and amplitude of the P1-N1 complex in the case and control groups( [Table 2](#TB1081or-2){ref-type="table"} ).

###### Cervical vestibular-evoked myogenic potentials in the case and control groups

                              Case group      Control group   *p* -value
  --------------------------- --------------- --------------- ------------
  Presence of cVEMPs, n (%)   30/30 (100%)    29/40 (72.5%)   0.001
  P1 (ms; mean ± SD)          14.74 ± 1.71    14.85 ± 1.70    0.858
  N1 (ms; mean ± SD)          23.76 ± 1.70    29.63 ± 2.19    0.422
  P1-N1 (µv; mean ± SD)       60.84 ± 29.63   77.53 ± 29.63   0.075

Abbreviations: cVemps, cervical vestibular-evoked myogenic potentials; SD, standard deviation.

Notes: P1 (ms) and M1 (ms), latency of each of the biphasic complexes in milliseconds; P1-N1 (µv) amplitude of the biphasic complexes in microvolts.

The case group was divided into four subgroups based on the etiology. The study showed that the patients with a history of bacterial meningitis did not have the biphasic P1-N1complex. This complex appeared in all of the patients with congenital HL, while it was only present in some patients with HL caused by virus (50%). The biphasic complex was monolaterally absent in some patients with high vascular and thrombophilic risk ( [Table 1](#TB1081or-1){ref-type="table"} ). Regarding the presence or absence of cVEMPs among the four subgroups of patients with HL, the data were statistically significant ( *p*  \< 0.001). The comparison between the latencies and amplitude of the P1-N1 complex in the sub-groups of patients with MPSHL was not statistically significant ( [Table 3](#TB1081or-3){ref-type="table"} ).

###### Cervical vestibular-evoked myogenic potentials in the sub-groups of cases

                             Bacterial meningitis   Vascular         Congenital      Viral             *p* -value
  -------------------------- ---------------------- ---------------- --------------- ----------------- ------------
  Presence of cVEMPs n (%)   0/4 (0%)               13/16 (71.25%)   12/12 (100%)    4/8 (50%)         \< 0.001
  P1 (ms; mean ± SD)         /                      13.82 ± 1.22     15.07 ± 1.96    15.05 ± 3.15      0.36
  N1 (ms; mean ± SD)         /                      22.67 ± 1.70     24.39 ± 2.07    23.75 ± 1.90      0.09
  P1-N1 (µv; mean ± SD)      /                      60.4 ± 30.57     45.87 ± 19.32   101.925 ± 15.74   0.02

Abbreviations: cVemps, cervical vestibular-evoked myogenic potentials; SD, standard deviation.

Notes: P1 (ms) and M1 (ms), latency of each of the biphasic complexes in milliseconds; P1-N1 (µv), amplitude of the biphasic complexes in microvolts.

Discussion
==========

Today, the number of publications concerning vestibular-evoked myogenic potentials (VEMPs) is rapidly increasing. This fact suggests that many clinicians and researchers have recognized clinical and scientific values of VEMPs that have clinical application in Meniere disease, vestibular neuritis, benign paroxysmal positional vertigo, vestibular migraine and central vertigo/dizziness. [@JR1081or-17] [@JR1081or-21] [@JR1081or-22] [@JR1081or-23] The analysis of utricle and saccule activity through VEMPs is not influenced by hypoacusis. Vestibular-evoked myogenic potentials are activated by a sound stimulus transmitted either by bone or by air, which sets in motion the ossicular chain and the intralabirintic liquids. The endolymph will activate the vestibular receptors, if functioning properly. The only case in which the hypoacusis can alter the vestibular response is otosclerosis, even if the utricle and saccule are perfectly functional. In this case, the transmission of sound at the level of the ossicular chain is blocked and therefore the endolymph cannot be moved. [@JR1081or-23] [@JR1081or-24] [@JR1081or-25] Different studies showed vestibular dysfunction in patients with sensorineural HL, especially children. [@JR1081or-1] [@JR1081or-24] There are few relevant studies on the association between vestibular deficit and MPSHL in adults. Disorders of the inner ear may result in a variety of manifestations, including vertigo, spatial disorientation, blurred vision, impaired articulation, and hearing impairment. Considering the diversity of clinical symptoms associated with PSHL with otolithic dysfunction, it may be frequently misdiagnosed, and objective means of testing the function of otolithic organs should be recommended for hearing-impaired patients. [@JR1081or-2] There is no correlation between the latency and amplitude of the early biphasic P1-N1 complex and the patient\'s age. The dysfunction can be anywhere in the VEMP reflex path. In a recent investigation, Xu et al [@JR1081or-25] detected cVEMP responses in 44.4% of ears in patients with PSHL, while the response rate was of 100% in healthy subjects. These data demonstrate that patients with PSHL have a high incidence of damage to the otolithic organs. Similarly, Xu et al [@JR1081or-24] investigated VEMP results in 43 children with PSHL and 20 healthy children, and found that cVEMPs were induced in 61.9% of ears in children with PSHL, while the response rate in the healthy children was of 100%. The literature data agree with the results of our study (cVEMP response in 71.5% of ears), considering also the fact that we have included subjects with moderate hearing loss. Disappearance and impairment of VEMPs could be observed after a cochlear implant (CI), and the waveforms of ocular VEMPs (oVEMPs) and cVEMPs could reflect the degree of damage to the utricle and saccule caused by the CI and other related factors. [@JR1081or-26] [@JR1081or-27]

Another aim of our study is to study the correlation between the etiology of HL and a possible alteration in labyrinthine function. The limitation of the present study is that in these subgroups the number of patients is too small, and, in the future, we hope to enroll a higher number of patients. With the diagnosis of HL after a viral pathology in childhood, a PCR investigation could be performed for the detection of viral antigens. The most recent works in the literature on deafness that arose after exanthematous disease are all based on the diagnosis made only through the anamnestic investigation. [@JR1081or-13] For the deafness of possible vascular origin, we limited ourselves to a numerous series of risk factors that the patient had to possess to be included in the study population. For the division into subgroups we relied on previous studies in the literature. [@JR1081or-12] [@JR1081or-13] [@JR1081or-14] [@JR1081or-15] [@JR1081or-16]

In the cases of HL due to a bacterial-viral cause, it is easier to find a concurrent vestibular disorder to a cochlear deficit, because of the close anatomical relationship that occurs between the two organs and the similarity of the receptor cells inside them. In the same way, in the case of meningitis, the close anatomical relationship with the cranial cavity plays a key role. [@JR1081or-12] In cases of postmeningitis bacterial deafness, cVEMPs were induced in 0% of ears, while the response rate was of 50% in the deafness of viral origin. In order to obtain a greater level of significance, these data require a greater sample. In the study by Tsubota et al, [@JR1081or-28] the virus was detected in the endolymph and in the perilymph. The proposed mechanisms of sensorineural HL include atrophy of hair cells in the organ of Corti and stria vascularis, and damage to the myelin sheath around the vestibulocochlear nerve. Vestibular dysfunction has also been reported in patients with mumps, suggesting that the eighth nerve is involved in the pathology because the utricle, saccule, and semicircular canals are not affected. [@JR1081or-13] [@JR1081or-28]

The response to cVEMPs is present in 100% of patients with non-syndromic congenital HL. In these patients, we identified a genetic mutation of the gap junction *β 2* ( *GJB2* ) gene, accounting for 50% of the cases of non-syndromic autosomal recessive HL. First described in 1997, GJB2 encodes connexin 26, a gap junction protein critical to the potassium-ion channels of the cochlea. [@JR1081or-7] [@JR1081or-14] [@JR1081or-29] These data suggest that the mutation of the *GJB2* gene does not damage the peripheral saccular receptor or the function of the inferior vestibular nerve. More studies on vestibular function in congenital deafness caused by intrauterine infections (cytomegalovirus, rubella and toxoplasmosis) would be useful.

The response to cVEMPs was monolaterally absent in 3 patients with high vascular and thrombophilic risk, coinciding with the ear with major hearing loss. This can direct us to identify a selective damage to the cochleo-vestibular artery, which vascularizes the cochlea, the macula of the saccule, and the ampulla of the posterior semicircular canal. Future studies using the oVEMPs or the video head impulse test (VHIT) are needed. Thanks to these non-invasive tests, we can identify ischemic damage to the anterior vestibular artery, which vascularizes the macula of the utricle and the ampulla of the superior and lateral semicircular canals, or damage to the labyrinthine artery, to the common branch of the vestibulo-cochlear artery, and to the anterior vestibular artery.

Conclusion
==========

The use of cVEMPs is essential in the diagnosis of saccular dysfunction in patients with MPSHL. The labyrinthine function should receive attention in the diagnosis and treatment of MPSHL. This is useful to identify and intervene promptly in cases of vestibular disorders, which could endanger the process of integration of the critical sensory stimuli for a correct posture and locomotion. [@JR1081or-30] [@JR1081or-31] [@JR1081or-32] [@JR1081or-33] [@JR1081or-34] The present study aims to increase the current knowledge about the etiopathogenesis of sensorineural HL, which is often of unknown nature, [@JR1081or-5] to set the correct therapeutic management to improve the quality of life of the patient.
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